Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ACAN.PA

Price
0.23
Stock movement up
+0.01 (2.56%)
Company name
Acanthe Développement
Exchange
(PA
,
Currency
EUR
)
Sector
Real Estate >
REIT - Office
Market cap
39.69M
Ent value
59.54M
Price/Sales
5.81
Price/Book
0.35
Div yield
-
Div growth
-
Growth years
-
FCF payout
14810.12%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
-29.41%
3 year return (CAGR)
-12.80%
5 year return (CAGR)
-10.29%
10 year return (CAGR)
-6.30%
Last updated: 2026-02-13

DIVIDENDS

ACAN.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF102.55
Price to FCF236.22
Price to EBITDA17.28
EV to EBITDA25.93

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales5.81
Price to Book0.35
EV to Sales8.72

FINANCIALS

Per share

Loading...
Per share data
Current share count165.35M
EPS (TTM)-0.10
FCF per share (TTM)0.00

Income statement

Loading...
Income statement data
Revenue (TTM)6.83M
Gross profit (TTM)4.46M
Operating income (TTM)-10.68M
Net income (TTM)-15.95M
EPS (TTM)-0.10
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)65.36%
Operating margin (TTM)-156.41%
Profit margin (TTM)-233.60%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.22M
Net receivables17.52M
Total current assets0.00
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets133.12M
Accounts payable0.00
Short/Current long term debt67.00K
Total current liabilities0.00
Total liabilities21.07M
Shareholder's equity112.05M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)387.00K
Capital expenditures (TTM)219.00K
Free cash flow (TTM)168.00K
Dividends paid (TTM)24.88M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-14.23%
Return on Assets-11.98%
Return on Invested Capital-14.23%
Cash Return on Invested Capital0.15%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.24
Daily high0.24
Daily low0.24
Daily Volume12K
All-time high1.51
1y analyst estimate-
Beta0.44
EPS (TTM)-0.10
Dividend per share0.00
Ex-div date21 Aug 2024
Next earnings date23 Apr 2026

Downside potential

Loading...
Downside potential data
ACAN.PAS&P500
Current price drop from All-time high-84.96%-0.89%
Highest price drop-96.60%-56.47%
Date of highest drop26 Jan 19969 Mar 2009
Avg drop from high-58.06%-10.86%
Avg time to new high124 days12 days
Max time to new high5488 days1805 days
COMPANY DETAILS
ACAN.PA (Acanthe Développement) company logo
Marketcap
39.69M
Marketcap category
Small-cap
Description
ACANTHE DÉVELOPPEMENT is a European Company, with a capital of "22,468,153, whose registered office is located in Paris 8th, 55 rue Pierre Charron, and registered with the Paris Trade and Companies Register under number 735 620 205. ACANTHE DÉVELOPPEMENT shares are listed on Euronext Paris of NYSE Euronext (compartment C, ISIN FR 0000064602).
Employees
8
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Thinking about what to do with your GL Events shares? Whether you are sizing up an entry point or reassessing your position after a strong rally, now is a great time to take stock of what is really ha...
September 9, 2025
The cider brand has added a high-contrast NaviLens QR code to its cans.
September 9, 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
September 9, 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
September 9, 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
September 9, 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
September 9, 2025